Structure-function relationship between the human chemokine receptor CXCR3 and its ligands
- PMID: 12417585
- DOI: 10.1074/jbc.M209470200
Structure-function relationship between the human chemokine receptor CXCR3 and its ligands
Abstract
I-TAC, IP10, and Mig are interferon-gamma inducible CXC chemokines that share the same G-protein-coupled receptor CXCR3, which is preferentially expressed on Th1 lymphocytes. We have explored the structure-function relationship of the CXCR3 ligands, in particular of I-TAC, which has highest affinity for CXCR3 and is the most potent agonist. A potent antagonist for CXCR3 was obtained by NH(2)-terminal truncation of I-TAC. I-TAC (4-73), which lacks the first three residues, has no agonistic activity but competes for the binding of I-TAC to CXCR3-bearing cells and inhibits migration and Ca(2+) changes in such cells in response to stimulation with I-TAC, IP10, and Mig. It does also not induce internalization of CXCR3, which is in support of the lack of agonistic effects. Hybrid chemokines between I-TAC and IP10 were used to identify regions responsible for the higher activity of I-TAC. I-TAC-like IP10 analogs are obtained by substituting the NH(2) terminus (residues 1-8) or N-loop region (residues 12-17) of IP10 with those of I-TAC, suggesting that the differences in function of the CXCR3 ligands can be assigned to distinct regions and that these regions are interchangeable. Structure-activity studies with Mig showed that the extended basic COOH-terminal region, which is not present in I-TAC and IP10, is important for binding and activity.
Similar articles
-
The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3.J Biol Chem. 2001 Feb 2;276(5):2986-91. doi: 10.1074/jbc.M005652200. Epub 2000 Nov 10. J Biol Chem. 2001. PMID: 11110785
-
Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function.J Biol Chem. 2004 Jul 16;279(29):30219-27. doi: 10.1074/jbc.M403595200. Epub 2004 May 17. J Biol Chem. 2004. PMID: 15150261
-
Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.Blood. 2001 Dec 15;98(13):3554-61. doi: 10.1182/blood.v98.13.3554. Blood. 2001. PMID: 11739156
-
Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field.J Endocrinol Invest. 2003 Feb;26(2):177-80. doi: 10.1007/BF03345149. J Endocrinol Invest. 2003. PMID: 12739748 Review.
-
A review of the pleiotropic actions of the IFN-inducible CXC chemokine receptor 3 ligands in the synovial microenvironment.Cell Mol Life Sci. 2023 Mar 2;80(3):78. doi: 10.1007/s00018-023-04715-w. Cell Mol Life Sci. 2023. PMID: 36862204 Free PMC article. Review.
Cited by
-
CXCL10 activities, biological structure, and source along with its significant role played in pathophysiology of type I diabetes mellitus.Inflammation. 2013 Apr;36(2):364-71. doi: 10.1007/s10753-012-9555-1. Inflammation. 2013. PMID: 23065240 Review.
-
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C.Blood. 2005 Aug 15;106(4):1175-82. doi: 10.1182/blood-2005-01-0126. Epub 2005 Apr 28. Blood. 2005. PMID: 15860662 Free PMC article.
-
Targeting Members of the Chemokine Family as a Novel Approach to Treating Neuropathic Pain.Molecules. 2023 Jul 30;28(15):5766. doi: 10.3390/molecules28155766. Molecules. 2023. PMID: 37570736 Free PMC article. Review.
-
Expression of MIG/CXCL9 in cystic fibrosis and modulation of its activities by elastase of Pseudomonas aeruginosa.J Innate Immun. 2014;6(6):846-59. doi: 10.1159/000365399. Epub 2014 Aug 9. J Innate Immun. 2014. PMID: 25115612 Free PMC article.
-
The emerging role of CXCL10 in cancer (Review).Oncol Lett. 2011 Jul;2(4):583-589. doi: 10.3892/ol.2011.300. Epub 2011 May 9. Oncol Lett. 2011. PMID: 22848232 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous